ImageneBio (IMA) Accumulated Expenses (2020 - 2024)
Historic Accumulated Expenses for ImageneBio (IMA) over the last 5 years, with Q3 2024 value amounting to $3.8 million.
- ImageneBio's Accumulated Expenses fell 6625.57% to $3.8 million in Q3 2024 from the same period last year, while for Sep 2024 it was $3.8 million, marking a year-over-year decrease of 6625.57%. This contributed to the annual value of $8.6 million for FY2023, which is 285.27% up from last year.
- According to the latest figures from Q3 2024, ImageneBio's Accumulated Expenses is $3.8 million, which was down 6625.57% from $3.1 million recorded in Q2 2024.
- In the past 5 years, ImageneBio's Accumulated Expenses ranged from a high of $11.2 million in Q3 2023 and a low of $3.1 million during Q2 2024
- Over the past 5 years, ImageneBio's median Accumulated Expenses value was $5.4 million (recorded in 2020), while the average stood at $5.8 million.
- In the last 5 years, ImageneBio's Accumulated Expenses surged by 10503.31% in 2022 and then plummeted by 6625.57% in 2024.
- ImageneBio's Accumulated Expenses (Quarter) stood at $5.4 million in 2020, then grew by 8.37% to $5.9 million in 2021, then skyrocketed by 42.52% to $8.3 million in 2022, then increased by 2.85% to $8.6 million in 2023, then plummeted by 55.98% to $3.8 million in 2024.
- Its Accumulated Expenses was $3.8 million in Q3 2024, compared to $3.1 million in Q2 2024 and $4.8 million in Q1 2024.